Block & Leviton is investigating Cellebrite DI for potential securities law violations following the company's Q2 2026 earnings miss and a 32% stock drop. Cellebrite had previously assured investors of accelerating U.S. federal business and a strong government deal pipeline, but later revealed delays and weaker pricing that impacted revenue guidance. The company also replaced its CEO abruptly on the same day as the earnings report. The investigation focuses on whether Cellebrite adequately disclosed risks to its government contracts. Investors who lost money in Cellebrite stock may be eligible to recover losses through legal action led by Block & Leviton.
Institutional investors have significantly increased their holdings in Hyperliquid Strategies, a U.S.-listed digital asset treasury company, with ownership reaching 9.45%. This rise in institutional interest coincides with market predictions that Hyp...
XRP experienced its strongest ETF inflow week since May, with nearly $40 million in fresh capital following a price rally of almost 60%. The surge in demand was highlighted on August 21, when XRP's price rose over 20% in 24 hours, attracting $18.38 m...
Bitcoin surged 26% to nearly $79,500 in just five days due to a massive $3.1 billion short squeeze, triggering strong retail investor FOMO. Experts note that retail traders now have more market influence, especially through zero DTE options, with som...
Grayscale's Head of Research, Zach Pandl, identifies three key reasons why now could be a favorable time to buy Bitcoin for investors with a long-term perspective: ongoing adoption trends, the bear market nearing typical cycle length, and a supportiv...
XRP surged 40% over the past week to $1.40, its highest since May 18, driven by a broader crypto market rally led by Bitcoin surpassing $77,000. The rise is supported by increased trading volume nearing $10 billion and new money entering via derivati...
